The Role of Biomaterials in Enhancing Cell Therapy

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Materials Science

Background:

• Cell-based therapies offer regenerative and immunomodulatory potential for diseases like cancer and diabetes.
• Clinical translation faces hurdles including immune rejection, poor cell viability, and delivery control.
• Biomaterials present solutions to overcome these barriers in cell therapy.

Purpose of the Study:

• To review advances in biomaterial strategies for cell-based therapies.
• To highlight how biomaterials address challenges in clinical translation.
• To discuss the application of biomaterials across various cell therapy types.

Main Methods:

• Review of biomaterial strategies including nanoparticles, hydrogels, scaffolds, and layer-by-layer assemblies.
• Analysis of biomaterial applications in T-cell, macrophage, stem cell, and islet cell therapies.
• Evaluation of physicochemical and mechanical properties of different material classes.

Main Results:

• Biomaterials create supportive environments, enhance cell survival, and enable targeted delivery.
• Specific material classes offer tunable properties for diverse cell types and therapeutic needs.
• Biomaterials are critical tools for improving cell therapy efficacy and precision.

Conclusions:

• Biomaterials are essential for advancing cell-based therapies, overcoming key clinical translation barriers.
• Challenges include selecting appropriate biomaterials and ensuring long-term biocompatibility.
• Patient-specific and adaptable biomaterials promise future breakthroughs in regenerative medicine.